Journal of Clinical Endocrinology & Metabolism, Vol 73, 132-139, Copyright © 1991 by Endocrine Society

ARTICLES

The orthostatic tachycardia syndrome: evaluation of autonomic function and treatment with octreotide and ergot alkaloids

RD Hoeldtke and KM Davis
Department of Medicine, Temple University School of Medicine, Philadelphia, Pennsylvania 19140.

Orthostatic tachycardia is a poorly understood syndrome in which patients develop dizziness, diaphoresis, or palpitations upon shifting from the supine to the upright posture. The present study was performed to determine whether autonomic neuropathy might be present in these patients, and whether the abnormal hemodynamic response to standing might be the result of failure of reflex vasoconstriction. We measured autonomic function in 9 patients with idiopathic orthostatic tachycardia and 2 patients with orthostatic tachycardia and insulin- dependent diabetes mellitus and compared them to 33 age-matched controls. Although most patients with orthostatic tachycardia had normal vasomotor reflexes and normal surface potential amplitudes, the latency of the autonomic response, a measure of sympathetic nerve conduction velocity, was prolonged in the soles (2.44 +/- 0.08 s in patients with idiopathic orthostatic tachycardia vs. 2.12 +/- 0.04 s in controls; P less than 0.005). In 6 of 9 patients, however, the latencies were within the normal range. Autonomic surface potentials were absent in 1 diabetic patient with orthostatic tachycardia; the latency of the response in the feet was greatly prolonged (2.95 s) in the second patient. We also assessed the response of orthostatic tachycardia patients to octreotide and dihydroergotamine, which are known to have a pressor effect in patients with recognized forms of autonomic neuropathy. These agents, in combination, suppressed orthostatic tachycardia (from 116 +/- 7 to 89 +/- 6 beats/min; P less than 0.001) in patients with this syndrome. In summary, our data indicate that evidence of autonomic dysfunction is present in only a minority of patients with orthostatic tachycardia. Nevertheless, administration of the vasoconstrictor drugs dihydroergotamine and octreotide can prevent the abnormal hemodynamic response to the upright posture shown by patients with this syndrome.

This article has been cited by other articles:

				J. K. Brooks and L. A.P. Francis Postural orthostatic tachycardia syndrome: Dental treatment considerations J Am Dent Assoc, April 1, 2006; 137(4): 488 - 493. [Abstract] [Full Text] [PDF]

				N. Muenter Swift, N. Charkoudian, R. M. Dotson, G. A. Suarez, and P. A. Low Baroreflex control of muscle sympathetic nerve activity in postural orthostatic tachycardia syndrome Am J Physiol Heart Circ Physiol, September 1, 2005; 289(3): H1226 - H1233. [Abstract] [Full Text] [PDF]

				S. R. Raj, I. Biaggioni, P. C. Yamhure, B. K. Black, S. Y. Paranjape, D. W. Byrne, and D. Robertson Renin-Aldosterone Paradox and Perturbed Blood Volume Regulation Underlying Postural Tachycardia Syndrome Circulation, April 5, 2005; 111(13): 1574 - 1582. [Abstract] [Full Text] [PDF]

				G. Jacob, F. Costa, and I. Biaggioni Spectrum of Autonomic Cardiovascular Neuropathy in Diabetes Diabetes Care, July 1, 2003; 26(7): 2174 - 2180. [Abstract] [Full Text] [PDF]

				S. Yusuf and A. J. Camm Sinus Tachyarrhythmias and the Specific Bradycardic Agents: A Marriage Made in Heaven? Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2003; 8(2): 89 - 105. [Abstract] [PDF]

				R. Freeman, V. Lirofonis, W. B. Farquhar, and M. Risk Limb venous compliance in patients with idiopathic orthostatic intolerance and postural tachycardia J Appl Physiol, August 1, 2002; 93(2): 636 - 644. [Abstract] [Full Text] [PDF]

				J. Jordan, J. R. Shannon, A. Diedrich, B. K. Black, and D. Robertson Increased Sympathetic Activation in Idiopathic Orthostatic Intolerance: Role of Systemic Adrenoreceptor Sensitivity Hypertension, January 1, 2002; 39(1): 173 - 178. [Abstract] [Full Text] [PDF]

				M E V Petersen, T R Williams, C Gordon, R Chamberlain-Webber, and R Sutton The normal response to prolonged passive head up tilt testing Heart, November 1, 2000; 84(5): 509 - 514. [Abstract] [Full Text]

				G. Jacob, F. Costa, J. R. Shannon, R. M. Robertson, M. Wathen, M. Stein, I. Biaggioni, A. Ertl, B. Black, and D. Robertson The Neuropathic Postural Tachycardia Syndrome N. Engl. J. Med., October 5, 2000; 343(14): 1008 - 1014. [Abstract] [Full Text] [PDF]

				R. E. Shapiro, B. Winters, M. Hales, T. Barnett, D. A. Schwinn, N. Flavahan, and D. E. Berkowitz Endogenous Circulating Sympatholytic Factor in Orthostatic Intolerance Hypertension, October 1, 2000; 36(4): 553 - 560. [Abstract] [Full Text] [PDF]

				G. Jacob, J. R. Shannon, F. Costa, R. Furlan, I. Biaggioni, R. Mosqueda-Garcia, R. M. Robertson, and D. Robertson Abnormal Norepinephrine Clearance and Adrenergic Receptor Sensitivity in Idiopathic Orthostatic Intolerance Circulation, April 6, 1999; 99(13): 1706 - 1712. [Abstract] [Full Text] [PDF]

				R. Furlan, G. Jacob, M. Snell, D. Robertson, A. Porta, P. Harris, and R. Mosqueda-Garcia Chronic Orthostatic Intolerance : A Disorder With Discordant Cardiac and Vascular Sympathetic Control Circulation, November 17, 1998; 98(20): 2154 - 2159. [Abstract] [Full Text] [PDF]

				J. Jordan, J. R. Shannon, B. K. Black, S. Y. Paranjape, J. Barwise, and D. Robertson Raised Cerebrovascular Resistance in Idiopathic Orthostatic Intolerance : Evidence for Sympathetic Vasoconstriction Hypertension, October 1, 1998; 32(4): 699 - 704. [Abstract] [Full Text] [PDF]

				V. Novak, J. M. Spies, P. Novak, B. R. McPhee, T. A. Rummans, and P. A. Low Hypocapnia and Cerebral Hypoperfusion in Orthostatic Intolerance Stroke, September 1, 1998; 29(9): 1876 - 1881. [Abstract] [Full Text] [PDF]

				R. D. Hoeldtke and D. Streeten Treatment of Orthostatic Hypotension with Erythropoietin N. Engl. J. Med., August 26, 1993; 329(9): 611 - 615. [Abstract] [Full Text]